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Abstract. In radiation therapy, intensity maps involving margins have long
been used to counteract the effects of dose blurring arising from motion. More
recently, intensity maps with increased intensity near the edge of the tumour (edge-
enhancements) have been studied to evaluate their ability to offset similar effects that
affect tumour coverage. In this paper, we present a mathematical methodology to
derive margin and edge-enhanced intensity maps that aim to provide tumour coverage
while delivering minimum total dose. We show that if the tumour is at most about twice
as large as the standard deviation of the blurring distribution, the optimal intensity
map is a pure scaling increase of the static intensity map without any margins or
edge-enhancements. Otherwise, if the tumour size is roughly twice (or more) the
standard deviation of motion, then margins and edge-enhancements are preferred,
and we present formulae to calculate the exact dimensions of these intensity maps.
Furthermore, we extend our analysis to include scenarios where the parameters of the
motion distribution are not known with certainty, but rather can take any value in
some range. In these cases, we derive a similar threshold to determine the structure of
an optimal margin intensity map.
Submitted to: Phys. Med. Biol.
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1. Introduction
The use of margins has long been studied and implemented in practice as a technique to
mitigate the effects of any phenomenon that may degrade treatment quality in radiation
therapy. Margins have been employed to combat everything from setup uncertainty
to motion to imaging artifacts (International Commission on Radiation Units and
Measurements 1999). Their ubiquity in treatment planning is a testament to their
effectiveness, relative ease of implementation, but also lack of dominant substitutes.
Due to the inherent trade-off in using a margin (increased likelihood of tumour coverage
versus increased dose to the healthy tissue), the question of minimizing the size of
the margin while maintaining its efficacy is of great interest. While many empirical
studies have focused on applying margins to clinical cases and proposed methods
to reduce the size of the margin, others have taken a more theoretical approach
to analyzing margins and produced rules of thumb to govern their design (Balter
et al. 1995, Goitein 1985, Ekberg et al. 1998, Roach et al. 1994, van Herk et al. 2000). In
particular, the seminal work presented in (van Herk et al. 2000) generated a significant
leap in the understanding and design of margins. One of the goals of this paper will be to
introduce a new method of determining optimal margins in the face of (known) motion,
and produce rules of thumb that tell us when to use a margin and exactly what size it
should be. We will focus on parameters specific to an individual such as tumour size
and standard deviation of motion in order to deterministically derive tailored margins.
We will characterize optimal margin intensity maps (i.e., the derived margin width) in
the presence of motion with a known distribution. Through our analysis, we will also
address the question of when it may be advantageous to simply increase the intensity
of the static beam without a margin expansion. Our effort to derive optimal margins
is similar to calculating ideal spatial dose distributions (Sir et al. 2006), though our
mathematical formulations are different.
The concept of an “edge-enhanced” intensity map was first introduced and studied
in the context of mitigating the effects of beam penumbra (Biggs and Shipley 1986, Lind
et al. 1993, Mohan et al. 1996, Dirkx et al. 1997, Brugmans et al. 1999, Sharpe
et al. 2000). More recently, edge-enhanced intensity maps have been used to combat
the effects of motion when the distribution is known (Lof et al. 1995, Unkelbach and
Oelfke 2004, Trofimov et al. 2005) and motion when the distribution is unknown (Chan
et al. 2006, Bortfeld et al. 2008). Edge-enhanced intensity maps are characterized by
areas of high intensity at the edge of the tumour, coupled with lower, uniform intensity
in the interior of the tumour. In the face of motion uncertainty, edge-enhancements
were optimized to be a specific combination of intensity-modulation and intensity-
homogeneity that allowed the intensity map to effectively balance the competing
requirements of dose minimization and tumour coverage (Bortfeld et al. 2008). Though
these edge-enhanced intensity maps have become more prevalent in the literature
through empirical studies, there has been no analytical characterization of their
“optimal” size. Therefore, the second aim of this paper is to provide the first such
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characterization (i.e., specify the derived height and width of the edge-enhancements),
along the lines of the analysis we will conduct for optimal margin sizes and known
motion.
The third topic we will address is the topic of robustness and motion uncertainty.
It is important to understand the effects of motion when we do not have a complete
characterization of its distribution since wrongly assuming the reproducibility of a
specific motion trajectory can cause serious dosimetric errors (Sheng et al. 2006). This
is what we refer to as “motion uncertainty”. It is well understood that motion may have
a large impact on treatment quality (Bortfeld et al. 2002, Goitein 2004, Webb 2006), but
much analysis and experimentation often hinges on the knowledge of said motion (Zhang
et al. 2004, Trofimov et al. 2005, Unkelbach and Oelfke 2004). If the motion is perfectly
reproducible, periodic or known with certainty, we do not consider it a source of
uncertainty. That is not to say it does not have the potential to seriously degrade
the quality of a treatment. We simply separate into two situations the cases where
we assume a known motion distribution and its associated parameters, and those cases
where the exact motion distribution is not completely specified a priori (i.e., motion
uncertainty). Therefore, the third aim of this paper will be to extend our optimal
margin analysis from the realm of known motion to motion uncertainty. More precisely,
we will explore the sensitivity of solutions to motion uncertainty and demonstrate that
optimized margins can easily be derived to mitigate this uncertainty.
The rest of the paper will be organized as follows. In Section 2, we describe
the problem geometries to be analyzed, the structural characteristics of margin and
edge-enhanced intensity maps, the type of motion and motion uncertainty under
consideration, and the mathematical formulations used to derive the optimal intensity
maps. In Section 3, we will address the following three questions:
(i) What is the analytical structure of an optimal margin intensity map in the presence
of motion with a known distribution (also, when is a positive margin better than
simply increasing the intensity, with no margin expansion)?
(ii) How does the analytical structure of a margin intensity map change to compensate
for motion with an unknown distribution (also, how sensitive are treatment plans
to motion uncertainty)?
(iii) What is the analytical structure of an optimal edge-enhanced intensity map in the
presence of motion with a known distribution (also, when are edge-enhancements
better than margins or simply increasing the intensity)?
Last, we synthesize our findings in Section 4. Portions of this work are derived
from (Chan 2007), where the mathematical proofs that are omitted from this paper
may be found.
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2. Methods
In this paper, we focus on one-dimensional geometries, though an extension to three
dimensions is summarized in Appendix C and described in full detail in (Chan 2007).
Initially, the one-dimensional tumour is subjected to motion following a one-dimensional
Gaussian distribution with known mean and standard deviation. The first objective is
to design static intensity maps (restricted in structure to margin and edge-enhanced
intensity maps) that simultaneously ensure tumour coverage, while minimizing the total
dose delivered. Then, we extend our analysis to consider motion uncertainty, where the
mean and standard deviation of the Gaussian are not known with certainty, but lie in
intervals representing a range of possible parameter values. As a result, the structure
of the optimal static intensity maps are revised to take into account the parameter
uncertainty.
In the next few subsections, we specify the geometries considered, introduce
mathematical notation that will be used throughout the remainder of this paper, and
present the optimization formulations that will be used to derive both kinds of optimal
intensity maps.
2.1. Problem setup
We consider a one-dimensional tumour of length t, centered at the origin, that requires
one unit of dose (uniformly) throughout. This geometry is used primarily to build
intuition and motivate further analyses on this topic. The tumour is subjected to
Gaussian motion with mean µ and standard deviation σ. The motivation for this
motion model is multi-fold. First, motion that is not Gaussian by nature (e.g., breathing
motion) has been observed to converge to a Gaussian distribution if baseline corrections
are not made (Engelsman et al. 2005). Second, random setup uncertainty is a type
of motion that has been shown to follow a Gaussian distribution (Schewe et al. 1996).
Third, extensions of this analysis to multiple sources of uncertainty will be aided by
assuming a Gaussian distribution since many errors with arbitrary distributions will
converge to a Gaussian. In fact, one could interpret the two Gaussian parameters
as incorporating two different types of uncertainty: σ for random errors and µ for
systematic errors. Fourth, a practical consideration is that a Gaussian has attractive
analytical properties that facilitate the subsequent analysis. While we have focused
on one-dimensional Gaussian motion, extensions to multiple dimensions (especially
with radial symmetry) are logical follow-ons. We will use φ to denote the standard
normal (Gaussian) probability density function (PDF) and Φ to denote its cumulative
distribution function (CDF):
φ(x) =
1√
2pi
e−x
2/2, Φ(x) =
∫ x
−∞
φ(z)dz. (1)
In the case of motion uncertainty, we assume that the uncertain mean, µ˜, lies in
the interval [µ, µ] and similarly, σ˜ lies in the interval [σ, σ]. While the true mean and
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standard deviation can be anywhere in their respective intervals (and therefore unknown
a priori), the endpoints of these intervals are assumed to be known. Therefore, the
determination of intensity maps that ensure tumour coverage need to account for all
possible means and standard deviations in these intervals. It is important to make the
distinction between “motion” versus “motion uncertainty” here. In the first case, the
mean and standard deviation of the Gaussian are known a priori, so while there is motion
present, it does not necessarily imply uncertainty (only that we must appropriately
account for this motion). On the other hand, motion uncertainty implies there is
some specific aspect of the motion that is unknown to us and only can be learned
upon treatment (or retrospectively). We may assume the motion belongs to a certain
family of distributions and that its parameters are within some general bounds, but
the exact values of these parameters are unknown during the treatment design phase.
Therefore, not only must we account for the motion, we must also account for all of the
different possible motion distributions that may be realized for different realizations of
the underlying parameters.
Finally, we ignore the effects of geometric and radiation penumbrae. While this
assumption is mainly for the sake of analytical convenience, it is not particularly
restrictive. First, the dosimetric effects of geometric penumbra tend to be negligible
and dominated by those of the radiation penumbra (Thomas 1994). Furthermore, both
effects can be modeled using Gaussian distributions (Ulmer and Harder 1995). Since
the sum of Gaussian random variables is Gaussian (Bertsekas and Tsitsiklis 2002), we
may assume that the Gaussian motion distribution used in this paper also accounts for
the effects of these other penumbrae; this is another benefit of modeling the motion as a
Gaussian. Even though we only focus on motion, the results presented in this paper can
be interpreted as including multiple penumbrae by simply decomposing the Gaussian
standard deviation into its component parts: separate terms for motion, geometric
penumbra, and radiation penumbra. Therefore, references to the standard deviation of
motion can be thought of as the standard deviation of the blurring distribution (that
might be comprised of all three penumbra effects).
Now, let us define the two families of intensity maps to which we will restrict our
search of optimal solutions: margins and edge-enhancements.
2.2. Margin intensity maps
In the absence of motion, the optimal intensity map is a “square wave” with a
height of one, length of t, and centered on the tumour – that is, it replicates the
shape of the tumour exactly. In the presence of motion, the dose delivered is
blurred (Bortfeld et al. 2004), which mathematically corresponds to a convolution
of the motion probability density function (PDF) with the static delivered intensity
map (Lujan et al. 1999, Engelsman et al. 2005, Bortfeld et al. 2002). In our setup, when
the square wave intensity map is convolved with a Gaussian, the resulting function has
a height strictly less than one (due to the fact that the Gaussian integrates to one and
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is positive on the entire real line), which means that the tumour is being underdosed.
There are two options to improve tumour coverage. One possibility is simply to deliver
more than one unit of dose in the initial intensity map. The other possibility is to add a
positive, isotropic margin around the tumour. Note that in the second case, a positive
scaling (increase) of the intensity will still be required to achieve coverage (again, due
to the convolution with the Gaussian). Our goal is to find a margin intensity map that
minimizes the total dose delivered while ensuring that sufficient dose is delivered to the
tumour even after the intensity map is convolved with a Gaussian PDF. As part of this
analysis, we will determine precisely when an optimal intensity map should have no
margin (and simply scale the initial intensity map of length t) versus when an optimal
intensity map should have a positive margin. Figure 1 illustrates the dose blurring,
margin, and intensity scaling concepts.
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Figure 1. Dose delivered using a margin plus intensity scaling.
Let us now precisely define some notation and the concept of a margin intensity
map. A margin intensity map has an isotropic margin of width m ≥ 0 around an
intensity map with the same width as the tumour, resulting in an intensity map of
width of t + 2m. Formally, we define a static intensity map with a margin of size m,
centered at the origin, to be
δm(x) =
{
1, x ∈ [−t/2−m, t/2 +m],
0, otherwise.
(2)
Furthermore, we define dm(y;µ, σ) to be the dose delivered to point y, when a static
intensity map with margin size m is convolved with a Gaussian PDF with mean µ and
standard deviation σ. Hence,
dm(y;µ, σ) = Φ
(
y + t/2 +m− µ
σ
)
− Φ
(
y − t/2−m− µ
σ
)
. (3)
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Intuitively, an optimal intensity map should be centered on the tumour, so without loss
of generality, we assume that µ = 0 so that the tumour, the intensity map, and the
delivered dose profile are all centered at the origin.
With a margin of size m, the total dose delivered before scaling the intensity map
is t + 2m. Let γ be a variable that defines the multiplicative factor by which the total
intensity map is scaled. We then have the following mathematical formulation of the
problem of finding an intensity map that ensures tumour coverage at lowest total dosage:
minimize
m,γ
γ(t+ 2m)
subject to γdm(y; 0, σ) ≥ 1, ∀ y ∈ [−t/2, t/2],
m, γ ≥ 0.
(4)
For a given margin sizem, we define γ∗m to be the optimal (minimal) scaling factor. Note
that γ should be as small as possible while ensuring the constraint in (4) is satisfied; this
implies that at some point y in the tumour, the constraint should hold with equality.
Given the symmetry and unimodal natures of both the tumour and the Gaussian, the
lowest point of dose in the tumour after convolution will be at its edge (at y = t/2 or
y = −t/2). As long as the edge of the tumour receives enough dose, the entire tumour
will receive enough dose. By inserting y = t/2 or y = −t/2 into the constraint in (4)
and changing it to an equality, we get the following equation for γ∗m:
γ∗m =
1
Φ( t+m
σ
)− Φ(−m
σ
)
=
1
Φ(m
σ
)− Φ(−t−m
σ
)
. (5)
Using the equation for γ∗m, formulation (4) can be simplified to:
minimize
m
f(m)
subject to m ≥ 0,
(6)
where
f(m) := γ∗m(t+ 2m) =
t+ 2m
Φ( t+m
σ
)− Φ(−m
σ
)
. (7)
The function f(m) describes the total dose delivered by an intensity map that
ensures tumour coverage, as a function of m. Our goal is to derive an optimal margin
size (optimal value for m, from which the optimal scaling factor γ∗ will follow) for any
problem instance (a given t and σ). Section 3.1 summarizes the results of our analysis.
2.3. Margins under uncertainty
In the case of motion uncertainty, we have an uncertain mean, µ˜, and standard deviation
σ˜, that may lie anywhere in the range [µ, µ] and [σ, σ], respectively. These intervals
characterize the range of possible realizations of the uncertain parameters. As in
formulation (4), our objective is to minimize the total dose delivered while ensuring
tumour coverage. However, with an uncertain mean and standard deviation, we wish
to ensure tumour coverage under any possible realization of µ˜ and σ˜. An intensity map
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that guarantees tumour coverage while minimizing total dose in this situation will be
called an optimal “robust” solution.
The quantity µ˜ can be dealt with in a straightforward manner. The requirement
of tumour coverage for all µ˜ ∈ [µ, µ] is equivalent to requiring tumour coverage for a
tumour that is µ− µ units larger than t. Thus, we center the beam at (µ+ µ)/2, shift
the origin of our coordinate system to this location, and define the “effective tumour”
as the interval [−t/2− (µ− µ)/2, t/2+ (µ− µ)/2]. The effective tumour is the minimal
region that needs to be irradiated to the desired dose level.
With µ˜ accounted for, let us pose our robust optimization problem as:
minimize
m,γ
γ(t+ 2m)
subject to γdm(y; 0, σ˜) ≥ 1, ∀ y ∈ {effective tumour},∀ σ˜ ∈ [σ, σ],
m, γ ≥ 0.
(8)
Problem (8) appears to have a very similar structure to problem (4). In fact it turns
out that they have the same structure when suitable adjustments are made for the
uncertainty in the mean and standard deviation. In particular, problem (8) is equivalent
to
minimize
m
t+ 2m
Φ( t+m
σ
)− Φ(−m
σ
)
subject to m ≥ 0,
(9)
where t = t + µ − µ. In other words, if we replace t with t + µ − µ (the size of the
effective tumour) and σ with σ (the maximal standard deviation in its range), all of the
results and intuition derived for the “no uncertainty” case hold. To understand how
we get formulation (9), consider the dose delivered function accounting for the effective
tumour, margin of size m and σ˜:
dm(y; 0, σ˜) = Φ
(
y + t/2 +m+ (µ− µ)/2
σ˜
)
− Φ
(
y − t/2−m− (µ− µ)/2
σ˜
)
. (10)
To determine γ∗m, we follow the same argument as in Section 2.2. For any σ˜, the lowest
dose delivered to the effective tumour will occur at its edge. Since larger values of σ˜
increase the spread of dose or dose blurring (the function d decreases with increasing
σ˜), we need to protect against the largest value of σ˜, namely, σ. Therefore, plugging
y = t/2 + (µ − µ)/2 and σ˜ = σ into the equation for dm(y; 0, σ˜), setting its reciprocal
equal to γ, and replacing γ in the objective function of formulation (8), we arrive at the
equivalent formulation (9). Our goal is to derive an optimal margin size (optimal value
for m) for any problem instance of the robust problem (a given t, [µ, µ], and [σ, σ]).
Section 3.2 summarizes the results of our analysis.
2.4. Edge-enhanced intensity maps
Edge-enhancements differ from margins in that they provide the flexibility to scale the
intensity delivered around the edge of the tumour without modifying the intensity near
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the middle of the tumour. We adopt a stylized model of edge-enhancements where the
increased intensity delivered at the edge of the tumour is uniform across the increase
(a rectangular “horn”). An edge-enhanced intensity map retains the margin variable m,
but adds a variable l that describes the width of the part of the edge-enhancement that
extends into the tumour. Finally, there is a variable h that describes the height of the
edge-enhancements above the desired dose level. Note the difference between h and γ
from the margin intensity map. Variable h is an additive amount above the required
dose level, whereas γ was a multiplicative factor that scales the entire intensity map (for
example, h = 1 means that the maximum height of the edge-enhanced intensity map is 2,
whereas γ = 1 means that the maximum height of the margin intensity map is 1). Due to
the symmetry of the Gaussian distribution, we only consider symmetric intensity maps;
however, it would be possible to construct a non-symmetric edge-enhanced intensity map
if the motion distribution was skewed in a certain direction (a skewed motion distribution
and non-symmetric edge-enhancements were observed in (Chan et al. 2006)). Figure 2
illustrates the relevant variables associated with an edge-enhanced intensity map.
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Figure 2. An edge-enhanced intensity map.
As before, we assume that the beam of radiation is centered on the tumour, and
both are centered at the origin. We define the static edge-enhanced intensity map,
δm,l,h(x), to be:
δm,l,h(x) =

1, x ∈ (−t/2 + l, t/2− l),
1 + h, x ∈ [−t/2−m,−t/2 + l] ∪ [t/2− l, t/2 +m],
0, otherwise.
(11)
We constrain l to be at most t/2, since the two edge-enhancements would overlap if
l > t/2. Furthermore, note that the special case where l = t/2 is exactly the margin
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problem from the previous subsection (except for the slight difference in interpretation
between h and γ mentioned earlier).
Convolving δm,l,h(x) with a Gaussian PDF with mean µ and standard deviation σ,
we write the delivered dose dm,l,h(y;µ, σ), as a function of y, as
dm,l,h(y;µ, σ) = (1 + h)Φ
(
y + t/2 +m− µ
σ
)
− hΦ
(
y + t/2− l − µ
σ
)
+ hΦ
(
y − t/2 + l − µ
σ
)
− (1 + h)Φ
(
y − t/2−m− µ
σ
)
.
(12)
The total dose delivered is simply the area under the edge-enhanced intensity map,
which is f(m, l, h) := 2(m + l)(1 + h) + t − 2l = t + 2m + 2(m + l)h. Hence, we can
formulate the problem as follows
minimize
m,l,h
t+ 2m+ 2(m+ l)h
subject to dm,l,h(y; 0, σ) ≥ 1, ∀ y ∈ [−t/2, t/2],
l ≤ t/2,
m, l, h ≥ 0.
(13)
Similar to how γ∗ was written as a function of m in the margin case, the optimal
value of h can be written as a function of m and l. This relies on the fact that the
edge of the tumour is the most susceptible to being underdosed. The validity of this
statement is not obvious; it might seem possible for an edge-enhanced intensity map to
ensure sufficient dose to the tumour’s edge but not its center. But we can prove that
as long as the edge of the tumour receives enough dose, the middle of the tumour is
guaranteed to also receive enough, for any edge-enhanced intensity map. Conversely,
if the middle of the tumour is underdosed, then the edge of the tumour will also be
underdosed. These statements require a formal proof, which is given in (Chan 2007).
After expressing h in terms of m and l, and after simplifying formulation (13), we arrive
at
minimize
m,l
f(m, l)
subject to m ≥ 0, 0 ≤ l ≤ t/2,
(14)
where
f(m, l) := t+ 2m+ 2(m+ l)
1− Φ( t+m
σ
) + Φ(−m
σ
)
Φ( t+m
σ
)− Φ(−m
σ
)− Φ( t−l
σ
) + Φ( l
σ
)
. (15)
As an aside, recall that setting l = t/2 recovers the margin problem. We can check this
easily by noting that
f(m, t/2) = t+
2m(1− Φ( t/2
σ
) + Φ( t/2
σ
)) + t(1− Φ( t+m
σ
) + Φ(−m
σ
))
Φ( t+m
σ
)− Φ(−m
σ
)− Φ( t/2
σ
) + Φ( t/2
σ
)
(16)
=
t+ 2m
Φ( t+m
σ
)− Φ(−m
σ
)
, (17)
which is the same as the objective function in the margin problem.
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Our goal is to derive an optimal edge-enhanced intensity map (optimal values form,
l and h) for any problem instance (a given t and σ). In Section 3.3, we will demonstrate
our solution to this optimization problem and its implications.
3. Results
The analytical results presented in the upcoming sections were derived by analyzing
the structure of the dose deposition functions f(m) (for margins) and f(m, l) (for
edge-enhancements). Complete details of the mathematical analyses conducted can
be found in (Chan 2007). All computational results were derived using simple function
minimization routines in the “Optimization Toolbox” in Matlab.
3.1. Optimal margins
3.1.1. Analytical results For every value of t and σ, there is a unique margin size m∗
that minimizes the total dose delivered function f(m). The ratio t/σ is all that is needed
to determine the structure of the optimal margin size. If t/σ ≤ u∗ ≈ 2.28, then the
optimal margin size is m∗ = 0. If t/σ > u∗, then the optimal margin size is positive,
and can be determined by solving a non-linear equation derived from the optimality
condition f ′(m) = 0:
2
(∫ m+t
σ
−m
σ
1
2σ
e−
x2
2 dx
)
− t+ 2m
σ
√
2pi
(
e−
(m+t)2
2σ2 + e−
m2
2σ2
)
= 0. (18)
It is important to note that the threshold u∗ is a fundamental constant derived in
our analysis and is independent of all the problem parameters. Its exact value is
only affected by our assumption that the underlying motion distribution is Gaussian.
Different distributions may result in different thresholds.
Figure 3 depicts the relationships between the optimal margin size, corresponding
scaling factor, and the tumour size. As the tumour size increases, the optimal margin
size increases and the intensity scaling decreases. Adding a larger margin reduces
the underdose to the tumour, and therefore, reduces the intensity scaling needed to
guarantee tumour coverage. Note that in practical situations where the extent of the
motion cannot be arbitrarily large, an optimal solution could involve a positive margin
without any intensity scaling (γ∗m∗ = 1). In our framework, this situation appears
(approximately) when the standard deviation is much smaller than the size of the
tumour, in which case the intensity scaling approaches 1. We provide an example
in Appendix B to show that the optimal intensity map may involve a margin with no
scaling of the intensity, when the motion PDF is positive only over a bounded domain.
3.1.2. Implications Our structural results establish that if the tumour size is no
more than 2.28 times the standard deviation of the motion (t/σ ≤ 2.28), then the
optimal margin size is 0. With a margin size of zero, tumour coverage is achieved
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Figure 3. The ratio of the optimal margin size to σ and optimal scale factor as a
function of the ratio of the tumour size to σ for a 1D tumour.
purely through a positive scaling of the intensity. This result has a very intuitive
interpretation. For small tumours, adding a margin around the tumour is less desirable
than simply increasing the intensity of the static intensity map because a margin would
be contributing a lot of dose relative to the size of the tumour. If t/σ < 2.28, then we
can think of the tumour as being roughly the same size as the magnitude of the motion,
which for realistic amplitudes, implies that the tumour is small. For example, if the
standard deviation of the motion amplitude is 0.5 cm, then t/σ < 2.28 implies that the
tumour is roughly 1 cm or smaller. On the other hand, if t/σ > 2.28, the motion can
be thought of as relatively small compared to the size of the tumour, and therefore,
adding a small margin around the tumour will only contribute a small increase in the
dose delivered to the healthy tissue, relative to the dose delivered to cover the tumour
itself. Furthermore, the non-linear equation (18) is easy to solve numerically, which
makes computing the optimal margin size straightforward.
3.2. Optimal margins under motion uncertainty
3.2.1. A motivational example We provide motivation by illustrating the negative
effects of motion uncertainty when intensity maps are not robust. Consider a tumour
spanning the interval [−1, 1], µ˜ ∈ [−1/2, 1/2], and σ˜ ∈ [1/2, 3/2]. If we ignore
or are unaware of the uncertainty and simply assume that µ = 0 and σ = 1 are
fixed, then t/σ = 2 < u∗ and the optimal intensity map would have m∗ = 0 and
γ∗m∗ = (Φ(2) − Φ(0))−1. However, suppose there is a shift in the mean and increased
dose blurring during treatment so that the realized mean is at 1/2 and the realized
standard deviation is 3/2. Then the dose at the edge of the tumour (y = 3/2) would be
γ∗m∗d(y; 1/2, 3/2)|y=3/2 ≈ 0.856, (19)
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which corresponds to an underdose of almost 15%. While simplified, this example is
meant to convey the importance of accounting for uncertainty in the parameters of the
motion distribution. It may be possible to use heuristics to generate robust intensity
maps, but we will see an example later on that further argues for the need of a rigorous
robust methodology.
3.2.2. Analytical results The uncertainty in the mean and standard deviation change
the structure of f(m) slightly, but the general principle described in Section 3.1.1 holds.
Instead of using the statistic t/σ, the relevant quantity is t/σ, where t = t + µ − µ.
With this modification, the results mirror the “no uncertainty” case. If t/σ ≤ u∗, then
the optimal margin size is 0 and tumour coverage at minimal dose is achieved purely
through a positive scaling of the intensity. If t/σ > u∗, then the optimal margin size is
positive, and can be determined by solving (18), with all instances of t and σ replaced by
t and σ, respectively. The relationship between the optimal margin size, scaling factor
and tumour size is exactly as shown in Figure 3, except with t and σ in place of t and
σ, respectively.
3.2.3. Implications These results formalize an underlying relationship between
robustness and the type of uncertainty. Loosely speaking, µ˜ and σ˜ are competing with
each other to affect the robust solution. Uncertainty in µ˜ increases the area that requires
radiation (effectively increasing the size of the tumour), while the largest possible
value of σ˜ affects the spread in the realized dose distribution (effectively increasing
the minimum dose requirement). Thus, it seems like a margin is an appropriate
compensatory tool for dealing with uncertainty in µ˜, while increasing the intensity of the
beam can offset an increased σ˜. The relationship between the ratio t/σ and u∗ ≈ 2.28
solidifies this intuition. If the uncertainty in µ˜ is large, then t will be large, and it is
more likely that the optimal robust solution will consist of a positive margin (i.e., when
t/σ > u∗). On the other hand, if σ is large, then it is more likely that the optimal robust
solution will be a pure intensity scaling with no positive margin (i.e., when t/σ < u∗).
Our intuition here is similar to that from the nominal (no uncertainty) case, but now
we are incorporating uncertainty in µ˜ and the largest value of σ˜ into the ratio.
3.2.4. A robust example We close this section by demonstrating that the optimal
robust solution from formulation (9) provides better dose minimization than a particular,
intuitive heuristic procedure. In principle, one way to generate a robust solution would
be to solve the nominal (no uncertainty) problem (4) for every realization of µ˜ and
σ˜, and then take the “union” of the resulting solutions. A robust solution generated
from this method would be the smallest intensity map that contains the intensity maps
corresponding to the solution of the nominal problem (4) for every realization of µ˜ and
σ˜. While this method produces an intensity map that ensures tumour coverage, this
intensity map will deliver more total dose than is necessary, as we show next.
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Let t = 2, µ˜ ∈ [−1/2, 1/2] and σ˜ = σ = 1 (no uncertainty in σ for simplicity).
Since t/σ < u∗, the solution to problem (4) will be a pure intensity scaling, whereas
the robust solution will involve a positive margin (since t/σ = 3 > u∗). Solving the
robust problem (9) with t = 3 results in a robust solution, R1, with a margin of size
m∗R1 = 0.539, and an intensity scaling factor of 1.418. Thus, the total dose delivered by
the robust solution, R1, is γ∗m∗(t+ 2m
∗) = 1.418(3 + 2 · 0.539) = 5.785.
The optimal solution for the nominal problem is m∗N = 0 with an intensity scaling
factor of 2.095. The heuristic robust intensity map, R2, generated from these nominal
solutions is
δR2(y) =
{
2.095, y ∈ [−t/2 + µ−m∗N , t/2 + µ+m∗N ] = [−1.5, 1.5],
0, otherwise,
(20)
which leads to a total delivered dose of 2 · 1.5 · 2.095 = 6.286 – roughly a 9% increase in
total dose delivered as compared to the robust solution R1.
In this example, while t is small relative to σ, the uncertainty in µ˜ forces the effective
tumour size over the threshold u∗ (i.e., t > u∗ > t). Thus, the heuristic robust intensity
map (i.e., union of nominal intensity maps) is a union of purely scaled intensity maps,
whereas the optimal robust intensity map involves a positive margin with a smaller
scaling factor. The example shows that there can be relatively significant gains in
terms of dose minimization by using the optimal robust solution from an appropriately
formulated mathematical problem (formulation (9)), as opposed to generating a robust
solution using a heuristic procedure involving only solutions of the no-uncertainty version
of the problem.
3.3. Optimal edge-enhancements
3.3.1. Analytical results As in the margin problem, we discovered that the optimal
edge-enhanced intensity map structure bifurcates into two cases, based on the ratio t/σ
and its relationship to a constant uˆ ≈ 2.11. If t/σ ≤ uˆ, then m∗ = 0 and l∗ = t/2. In
other words, the optimal solution involves a positive intensity scaling with no margin or
edge-enhancements. If t/σ > uˆ, then the optimal solution has edge-enhancements but
no margin: m∗ = 0 and l∗ ∈ (0, t/2). In this case, l∗ can be determined by solving a
non-linear equation derived from the optimality condition ∂f(m, l)/∂l = 0, with m = 0:∫ t
σ
0
1√
2pi
e−
x2
2 dx−
∫ t−l
σ
l
σ
1√
2pi
e−
x2
2 dx− l
σ
√
2pi
(
e−
(t−l)2
2σ2 + e−
l2
2σ2
)
= 0. (21)
Figures 4(a) and 4(b) show l∗/σ and h∗ as a function of t/σ, respectively. Figure 4(a)
shows that l/σ scales linearly with t/σ with slope 1/2 (i.e., l∗ = t/2 and no edge-
enhancements) until uˆ, at which point l∗ < t/2 and edge-enhancements emerge. It
appears that l∗/σ is quite sensitive to t/σ; indeed, l∗/σ decreases quickly for small
increases in t/σ beyond uˆ. Figure 4(b) shows the corresponding edge-enhancement
height h∗, which is the minimum height necessary to bring the dose at the edge of the
tumour up to the requirement. Initially, as t/σ grows, the tumour edge underdosage
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shrinks (think of the Gaussian as being convolved with a square wave that is becoming
wider), so h∗ follows suit. But when the ratio moves into the edge-enhancement region,
l∗ shrinks, so h∗ needs to grow in order to maintain tumour coverage at the tumour
edge.
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Figure 4. Optimal parameters of an edge-enhanced intensity map as a function of
the ratio of the tumour size to σ for a 1D tumour.
3.3.2. Implications Intuitively, we should not be surprised that uˆ < u∗. Since edge-
enhancements are a generalization of margins (recall that the margin analysis is a special
case of the edge-enhancement analysis when l = t/2), we would expect the threshold
for when edge-enhancements are optimal to be lower (in other words, satisfied by more
possible values of t/σ) than the corresponding one for margins.
Our results imply that either edge-enhancements or pure intensity scalings
demonstrate improved dose minimization over margins for any ratio t/σ. Furthermore,
when the optimal intensity map is edge-enhanced, the result that m∗ = 0 suggests that
the edge-enhancements should only be present inside the tumour and not expand into
the region surrounding the tumour. By allowing the flexibility of creating edge-enhanced
intensity maps, a margin will never be preferred, and instead edge-enhancements will
be used if t/σ is sufficient large. However, realistically deliverable intensity maps will
not permit arbitrarily thin and high edge-enhancements (which Figure 4(b) suggests
is optimal when t becomes large), so at some physical limit (which could be included
into the optimization problem (14) as a lower bound on l), margins will be used in
conjunction with edge-enhancements in order to create an optimal intensity map (i.e.,
both m∗ > 0 and 0 < l∗ < t/2).
Optimal margin and edge-enhanced intensity maps 16
4. Discussion and conclusions
In this paper, we presented a new methodological approach for determining margin and
edge-enhanced intensity maps that guarantee delivery of a minimally-sufficient amount
of dose to a tumour in the presence of Gaussian motion and motion uncertainty. We
believe our results can be used to guide treatment planning decisions by providing rules
of thumb or recipes for intensity map design.
In the case of margins, we found that if the ratio of the tumour size to the standard
deviation of motion is less than 2.28, then the optimal intensity map involves no margins
and is simply a pure scaling increase of the static intensity map to compensate for the
dose blurring created by motion. On the other hand, if the tumour is at least 2.28 times
the size of the standard deviation of motion, then an isotropic margin around the tumour
(along with an intensity scaling) is optimal in terms of providing tumour coverage at
minimal dose. For the latter, we derived a non-linear equation that when solved, provides
the optimal size of the margins. We also derived a formula that produces the optimal
scaling factor using the optimal margin size. These results buttress the intuition that
for small tumours (e.g., less than 1 cm in length/diameter), margins need not be used
and a pure intensity scaling can be enough to compensate for the dose blurring due to
motion (e.g., σ ≈ 0.5 cm).
We provided the first “robust” analysis of margin intensity maps in the presence
of motion uncertainty. We noted that the presence of motion itself is not necessarily
a source of uncertainty, but that uncertainty in the parameters (e.g., the mean and
standard deviation) of the motion distribution imply motion uncertainty. In this case,
we showed that the robust margin problem had the same structure as the nominal margin
problem, and therefore the 2.28 threshold remained valid when examining a modified
ratio of the effective tumour size divided by the maximum standard deviation. By adding
the magnitude of the uncertain range for the mean to the tumour size and dividing the
sum by the maximum value in the uncertain range for the standard deviation, this ratio
could be used to determine whether or not the optimal robust margin intensity map
had a positive margin or was a pure intensity scaling.
Finally, in the case of edge-enhancements, we found that if the ratio of the tumour
size to standard deviation of motion is less than 2.11, then again the optimal intensity
map is a pure scaling increase of the intensity. When this ratio is larger than 2.11, edge-
enhancements are optimal and we derived equations that generate the optimal values
of their height and width. Given the added flexibility that edge-enhancements afford
over margins, we found that edge-enhancements or pure intensity scalings will always
be preferred over margins, though realistically deliverable intensity maps may involve a
combination of edge-enhancements and margins. Edge-enhanced intensity maps could
be realized in practice using, for example, additional MLC apertures focused on the
tumour edge, which would be designed via optimization.
Logical extensions of the work presented in this paper include extending the robust
analysis to edge-enhanced intensity maps. Initial analytical and computational results
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are presented in (Chan 2007), but there is an opportunity for further exploration,
especially in the area of robust edge-enhancements. Extensions to higher dimensions
should be explored as well. We have extended the margin analysis to three dimensions
in Appendix C, but the extension to 3D edge-enhancements is fertile ground for further
research. Finally, explicit consideration of the type of neighbouring healthy tissue is
important. We used an objective of minimizing total dose, which is appropriate when
considering neighbouring parallel organs. Organs that are sensitive to the maximum
dose delivered (e.g., the spinal cord) would need to be analyzed differently.
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Appendix A. Derivation of the structure of the objective function f(m) in
Section 3.1
In this section, we give a flavour of the mathematical arguments used to justify
the results in this paper. As noted previously, all omitted proofs are provided
in (Chan 2007). As an example, we focus on the derivation of the structure of f(m) and
the subsequent results involving t/σ and u∗. Recall that
f(m) :=
t+ 2m
Φ( t+m
σ
)− Φ(−m
σ
)
. (A.1)
We can show that either:
(i) f(m) has a unique minimum at some m∗ > 0, or
(ii) f(m) has a unique minimum at m∗ = 0.
Let us define g(m) to be the denominator in the definition of f(m). Since g(m) equals
a certain area under the curve of the standard normal (Gaussian) probability density
function, it is strictly positive for m ≥ 0. By taking derivatives, it is easy to show that
g′(m) > 0 and g′′(m) < 0 for m ≥ 0. Next, we consider the first two derivatives of f(m):
f ′(m) =
2g(m)− (t+ 2m)g′(m)
g2(m)
(A.2)
and
f ′′(m) =
−(t+ 2m)g′′(m)g2(m)− (2g(m)− (t+ 2m)g′(m))2g(m)g′(m)
g4(m)
. (A.3)
Note that f(m) is continuous and differentiable. Also, f(m) > 0 for all m ≥ 0, and in
particular, limm→∞ f(m) = ∞. The two cases for the structure of f(m) are obtained
depending on whether or not f ′(m) has a positive root.
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If there is an m∗ > 0 that satisfies f ′(m∗) = 0, then m∗ must be a strict local
minimum because we have g′′(m) < 0 and
f ′′(m∗) =
−(t+ 2m∗)g′′(m∗)
g2(m∗)
> 0. (A.4)
Furthermore, such an m∗ is unique. To see why, consider the existence of another mˆ > 0
that satisfies f ′(mˆ) = 0. This mˆ must be a strict local minimum as well, but between
two strict local minimum there must be a strict local maximum due to the Intermediate
Value Theorem (with continuity of f ′(m)), which contradicts the fact that all stationary
points of f(m) are strict local minima. This covers the first possibility of the structure
of f(m).
On the other hand, if there is no m > 0 such that f ′(m) = 0, then we claim
f ′(m) > 0 for all m > 0. Suppose to the contrary that there exists mˆ > 0 such that
f ′(mˆ) < 0. Since f ′(m)→ 2 > 0 as m→∞, f ′(m) must cross 0 at some point, implying
the existence of a solution to f ′(m) = 0 on (mˆ,∞), which is a contradiction. Since f(m)
is increasing, it must be minimized at m = 0. This covers the second case.
Since f(m) → ∞ as m → ∞, the first case is equivalent to f ′(0) < 0 and the
second case is equivalent to f ′(0) ≥ 0. There is, therefore, a threshold that is crossed
if f ′(0) = 0. If we substitute m = 0 into the numerator of the equation for f ′(m), and
substitute u = t/σ into the subsequent equation, we get
h(u) :=
(∫ u
−u
1√
2pi
e−
x2
2 dx
)
− u√
2pi
(
1 + e−
u2
2
)
= 0. (A.5)
From here, it is straightforward to show that u∗ ≈ 2.28 is the only positive solution to
this equation (a simple plot suffices), and is a threshold that separates h(u) > 0 (for
0 < u < u∗) from h(u) < 0 (for u > u∗).
Appendix B. Example of an optimal margin intensity map with no
intensity scaling
Consider a tumour centered at the origin, occupying the interval [−1, 1]. If the motion
PDF is
p(x) =
{
1, x ∈ [−1/2, 1/2],
0, otherwise,
(B.1)
and the static intensity map is
δm(x) =
{
1, x ∈ [−1−m, 1 +m],
0, otherwise,
(B.2)
then the dose delivered as a function of the location, y, is
dm(y) :=
∫ ∞
−∞
δm(y − x)p(x)dx (B.3)
=
∫ min{y+1+m,1/2}
max{y−1−m,−1/2}
1 dx (B.4)
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=

y + 3/2 +m, if y ≤ −1/2−m,
1, if −1/2−m ≤ y ≤ 1/2 +m,
3/2 +m− y, if y ≥ 1/2 +m.
(B.5)
Note that we may restrict m to be between 0 and 1/2 since we can achieve tumour
coverage with any margin of size at least 1/2 (and no intensity scaling). The minimum of
dm(y) over y ∈ [−1, 1] occurs at y = ±1, and at those points, dm(−1) = dm(1) = 1/2+m.
Hence, the minimal intensity scaling factor is
γ∗m =
1
1/2 +m
(B.6)
and the total dose delivered is
f(m) :=
2 + 2m
1/2 +m
. (B.7)
The derivative of f(m),
f ′(m) =
−1
(1/2 +m)2
, (B.8)
is negative for all m ≥ 0. Thus, the optimal solution is to have a positive margin of size
1/2, and then no intensity scaling is needed.
Appendix C. Analysis of 3D margins
In this section, we provide an overview of the margin analysis extension to three
dimensions. A full analysis is available in (Chan 2007). In three dimensions, we consider
a spherical tumour moving according to a 1D Gaussian. We define a 3D margin as an
expansion of the spherical static intensity map in the direction of motion, as shown in
Figure C1.
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Figure C1. A two-dimensional slice of the three-dimensional static intensity map.
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Appendix C.1. Optimal 3D margins
With a spherical tumour in the presence of Gaussian motion, we observed that there
were points on the surface of the tumour that would receive no dose at all if no margin
was applied. The intuition is that the equatorial ring of points perpendicular to the
direction of motion do not receive dose from neighbouring parts of the static intensity
map during convolution. Therefore, we showed that a margin was always needed to
guarantee tumour coverage. The margin expanded the static intensity map in the
direction of motion, ensuring that the ring of points would receive a positive amount of
radiation after convolution. We derived a formula to calculate the exact margin size as
a function of t and σ.
Appendix C.2. Optimal 3D margins under motion uncertainty
Uncertainty in the Gaussian parameters resulted in a problem that was similar in
structure to the 1D version. Due to the uncertainty in the mean, the effective tumour was
no longer spherical, but elongated in the direction of motion. Therefore, the problematic
ring of points from the “no uncertainty” case disappeared, and the optimal 3D margin
intensity map had either a positive or zero margin, depending on the values of t and σ.
We derived a complex series of thresholds that determines whether a positive margin
or no margin is optimal. We also derived a general rule of thumb stating that if the
effective tumour was long and skinny (its length at least ∼8 times its width), then it was
possible for the optimal 3D margin size to be zero. Otherwise, the optimal 3D margin
would always be positive.
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